tiprankstipranks

Jonathan Lieber Insider Profile

4 Followers
Jonathan Lieber, Director at Decoy Therapeutics, holds 2.00K shares in Decoy Therapeutics (Ticker: DCOY), holds ― shares in Applied Genetic Technologies (Ticker: AGTC), holds 4.12K shares in Rallybio (Ticker: RLYB).
tipranks
Jonathan Lieber

Jonathan Lieber
Decoy Therapeutics (DCOY)
Director

Ranked #104,158 out of 108,921 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-84.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
97.07%
2.72%
0.21%
0.00%
A breakdown of Jonathan Lieber's holdings

Insider Roles

Repligen
(RGEN)
CFO
Rallybio
(RLYB)
CFO
Decoy Therapeutics
(DCOY)
Director
Ocugen
(OCGN)
CFO
Roles that Jonathan Lieber holds in companies

Most Profitable Insider Trade

Stock:
Ocugen
(OCGN)
Rating:Informative Buy
Date:Dec 02, 2016 - Dec 02, 2017
Return:+2.00%
The most profitable trade made by Jonathan Lieber

Jonathan Lieber's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Decoy Therapeutics
Sep 02, 2026
Director
Uninformative Buy
$5.35K
AGTC
Applied Genetic Technologies
Rallybio
Feb 23, 2026
CFO
Uninformative Buy
$69.44K
Ocugen
Dec 02, 2016
CFO
Informative Buy
9.70K
$0.00
Repligen
Sep 24, 2012
CFO
Uninformative Buy
$2.48M
List of latest transactions for each holding click on a transaction to see Jonathan Lieber's performance on stock

Jonathan Lieber insider profile FAQ

What is the percentage of profitable transactions made by Jonathan Lieber?
The percentage of profitable transactions made by Jonathan Lieber is 25%.
    What is the average return per transaction made by Jonathan Lieber?
    The average return per transaction made by Jonathan Lieber is -84.50%.
      What stocks does Jonathan Lieber hold?
      Jonathan Lieber holds: DCOY, AGTC, RLYB, OCGN, RGEN stocks.
        What was Jonathan Lieber’s latest transaction?
        Jonathan Lieber latest transaction was an Uninformative Buy of ―.
          What was Jonathan Lieber's most profitable transaction?
          Jonathan Lieber’s most profitable transaction was an Informative Buy of OCGN stock on December 2, 2016. The return on the trade was 2.00%.
            What is Jonathan Lieber's role in Decoy Therapeutics?
            Jonathan Lieber's role in Decoy Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.